INSERM UMR-S 1124, Université Paris Descartes, 45 rue des Saint-Pères, 75006 Paris, France.
INSERM UMR-S 1124, Université Paris Descartes, 45 rue des Saint-Pères, 75006 Paris, France.
Cytokine Growth Factor Rev. 2014 Oct;25(5):551-61. doi: 10.1016/j.cytogfr.2014.04.008. Epub 2014 May 9.
The promyelocytic leukemia (PML) protein is a tumor suppressor acting as the organizer of nuclear matrix-associated structures named nuclear bodies (NBs). The involvement of PML in various cell processes, including cell death, senescence or antiviral defense underlines the multiple functions of PML due to its ability to interact with various partners either in the cytoplasm or in the nucleus. The importance of paracrine signaling in the regulation of PML expression is well established. More recently, a growing body of evidence also supports PML as a key regulator of cytokine signaling. These findings shed light on unsuspected biological functions of PML such as immune response, inflammation and cytokine-induced apoptosis. Here we review the current understanding of the pleiotropic activities of PML on cytokine-induced signaling.
早幼粒细胞白血病(PML)蛋白是一种肿瘤抑制因子,作为核基质相关结构的组织者,这些结构被称为核体(NBs)。PML 参与多种细胞过程,包括细胞死亡、衰老或抗病毒防御,这突显了 PML 的多种功能,因为它能够在细胞质或细胞核中与各种伴侣相互作用。旁分泌信号在调节 PML 表达中的重要性已得到充分证实。最近,越来越多的证据也支持 PML 作为细胞因子信号的关键调节剂。这些发现揭示了 PML 在免疫反应、炎症和细胞因子诱导的细胞凋亡等未被察觉的生物学功能。在这里,我们回顾了目前对 PML 对细胞因子诱导信号的多效性活性的理解。